We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

35 hedge funds and large institutions have $3.58M invested in Surgalign Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 9

4% more capital invested

Capital invested by funds: $3.43M → $3.58M (+$153K)

3% less funds holding

Funds holding: 3635 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
10
Reduced
9
Closed
3
Calls
Puts
Net Calls
Net Calls Change

SRGA Hedge Fund Activity: Q4 2022 in Review

35 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2022, worth a combined $3.58M — up 4.5% from $3.43M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SRGA and 2 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 10 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $1.93M. The largest seller was Cooperman Leon G, exiting entirely with an estimated $435K sold.

  • 35 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2022, down from 36 in Q3 2022.
  • Funds reported $3.58M of Surgalign Holdings, Inc. Common Stock stock for Q4 2022, up 4.5% quarter-over-quarter.
  • 2 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2022 and 3 closed out, a net change of -1 holder.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q4 2022 was Armistice Capital, an estimated $1.93M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2022 was Cooperman Leon G, an estimated $435K sold.

Based on aggregated 13F filings for Q4 2022.